Current understanding of the molecular pathogenesis of T-ALL has allowed to identify several oncogenes aberrantly expressed in different subgroups of pediatric T-ALL, such as TLX1, TAL1, LYL1, TLX3 and HOXA genes [4]. This evidence concerns the gene TLX1 and acute lymphoblastic leukemia.